MoneyWorks4Me

Alkem Laboratories - Quaterly Results

15 Aug 2026 Evaluate
The June 2026 quarter revenue stood at Rs. 26677.30 millions, up 12.46% as compared to Rs. 23721.70 millions during the corresponding quarter last year.Net profit declined -8.40% to Rs. 5699.80 millions from Rs. 6222.60 millions.The company reported a good operating profit of 8731.60 millions compared to 7370.60 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 26677.30 23721.70 12.46 26677.30 23721.70 12.46 96639.10 88134.40 9.65
Other Income 1366.20 1165.80 17.19 1366.20 1165.80 17.19 5551.70 5070.60 9.49
PBIDT 8731.60 7370.60 18.47 8731.60 7370.60 18.47 29795.60 26632.60 11.88
Interest 175.20 127.90 36.98 175.20 127.90 36.98 572.90 761.10 -24.73
PBDT 8556.40 7385.60 15.85 8556.40 7385.60 15.85 27791.80 25871.50 7.42
Depreciation 572.20 588.90 -2.84 572.20 588.90 -2.84 2565.60 2836.10 -9.54
PBT 7984.20 6796.70 17.47 7984.20 6796.70 17.47 25226.20 23035.40 9.51
TAX 2284.40 574.10 297.91 2284.40 574.10 297.91 3375.00 2138.20 57.84
Deferred Tax 207.00 -519.30 -139.86 207.00 -519.30 -139.86 -945.00 -1363.10 -30.67
PAT 5699.80 6222.60 -8.40 5699.80 6222.60 -8.40 21851.20 20897.20 4.57
Equity 239.10 239.10 0.00 239.10 239.10 0.00 239.10 239.10 0.00
PBIDTM(%) 32.73 31.07 5.34 32.73 31.07 5.34 30.83 30.22 2.03

Alkem Laboratories Share Price

5397.50 -2.50 (-0.05%)
21-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1900.90
Dr. Reddys Labs. 1175.00
Cipla 1426.20
Lupin 2193.00
Zydus Lifesciences 1120.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: